NCT00183742View on ClinicalTrials.gov

Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

October 31, 2005

Study Completion Date

May 31, 2006

Conditions
CancerCarcinoma
Interventions
DRUG

liposomal doxorubicin and docetaxel

Trial Locations (1)

90033

U.S.C./Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

INDUSTRY

lead

University of Southern California

OTHER

NCT00183742 - Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere) | Biotech Hunter | Biotech Hunter